May 8 |
Aclaris Therapeutics, Inc. (ACRS) Q1 2024 Earnings Call Transcript
|
May 7 |
Aclaris Therapeutics (ACRS) Reports Q1 Loss, Tops Revenue Estimates
|
May 7 |
Aclaris Therapeutics GAAP EPS of -$0.24 beats by $0.03, revenue of $2.4M beats by $0.4M
|
May 7 |
Aclaris Therapeutics Reports First Quarter 2024 Financial Results and Provides a Corporate Update
|
May 6 |
Aclaris Therapeutics Q1 2024 Earnings Preview
|
Apr 30 |
Aclaris Therapeutics to Announce First Quarter 2024 Financial Results on May 7, 2024 and to Provide Corporate Update
|
Apr 23 |
Flare Therapeutics Appoints Douglas Manion, M.D., FRCP (C) as Chief Executive Officer
|
Apr 11 |
Favourable Signals For Aclaris Therapeutics: Numerous Insiders Acquired Stock
|